Autopsy report · NCT00859495
Trimodal Lung-Sparing Treatment of Pleural Mesothelioma
Cause of deathNo reason given
Life of this trial
- Registered 1 year 1 month after it had already started.
- Ran for about 4 years before it stopped.
- 9 participants enrolled.
- Results were posted on the registry 8 years 6 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Columbia University
- Sponsor type
- University, hospital or other
- Conditions
- Pleural Mesothelioma
- Interventions
- Doxorubicin; Cisplatin; Pemetrexed; Radiotherapy
- Participants
- 9
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.